Literature DB >> 18173740

Intracellular HMGB1 transactivates the human IL1B gene promoter through association with an Ets transcription factor PU.1.

Fumihiko Mouri1, Junichi Tsukada, Takamitsu Mizobe, Takehiro Higashi, Yasuhiro Yoshida, Yasuhiro Minami, Hiroto Izumi, Yoshihiko Kominato, Kimitoshi Kohno, Yoshiya Tanaka.   

Abstract

High mobility group box 1 protein (HMGB1), originally described as a non-histone, DNA binding protein, was recently identified as a late mediator of inflammation via its extracellular release from activated macrophages/monocytes. In the present study, we report that intracellular HMGB1 synergizes with a macrophage/monocyte-specific E26 transformation-specific sequence (Ets) transcription factor PU.1 to transactivate the promoter of the IL1B gene coding a 31-kDa proIL-1beta protein. The -131 to +12 IL1B promoter, which possesses a PU.1 binding motif essential for its transactivation, was induced when HMGB1 expression vector was transfected into murine RAW264.7 macrophage cells. Our glutathione S-transferase-pulldown and coimmunoprecipitation assays demonstrated direct physical interaction of HMGB1 with PU.1. Deletion of the PU.1 winged helix-turn-helix DNA-binding domain inhibited the association of the two proteins. In electrophoretic mobility shift assay using recombinant PU.1 protein, a ternary complex of PU.1, HMGB1 and PU.1-binding element within the IL1B promoter was generated. The importance of PU.1 was further supported by our observation that induction of the IL1B promoter was obtained only after PU.1 expression in PU.1-deficient murine EL4 thymoma cells. Thus, our data raise the possibility of a novel mechanism which sustains and amplifies inflammatory reactions through physical interaction of PU.1 with intracellular HMGB1 in macrophages/monocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18173740     DOI: 10.1111/j.1600-0609.2007.00981.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  12 in total

Review 1.  Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting.

Authors:  Georgina S Butler; Christopher M Overall
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

Review 2.  Purification and characterization of transcription factors.

Authors:  L I Nagore; R J Nadeau; Q Guo; Y L A Jadhav; H W Jarrett; W E Haskins
Journal:  Mass Spectrom Rev       Date:  2013-07-07       Impact factor: 10.946

3.  Coordinate activation of inflammatory gene networks, alveolar destruction and neonatal death in AKNA deficient mice.

Authors:  Wenbin Ma; Blanca Ortiz-Quintero; Roberto Rangel; Morgan R McKeller; Sara Herrera-Rodriguez; Eliseo F Castillo; Kimberly S Schluns; Mary Hall; Huiyuan Zhang; Woong-Kyung Suh; Hitoshi Okada; Tak W Mak; Yang Zhou; Michael R Blackburn; Hector Martinez-Valdez
Journal:  Cell Res       Date:  2011-05-24       Impact factor: 25.617

4.  Adipocyte expression of PU.1 transcription factor causes insulin resistance through upregulation of inflammatory cytokine gene expression and ROS production.

Authors:  Ligen Lin; Weijun Pang; Keyun Chen; Fei Wang; Jon Gengler; Yuxiang Sun; Qiang Tong
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-27       Impact factor: 4.310

Review 5.  HMGB1 is a therapeutic target for sterile inflammation and infection.

Authors:  Ulf Andersson; Kevin J Tracey
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

Review 6.  The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction.

Authors:  Daniel J Weber; Yohance M Allette; David S Wilkes; Fletcher A White
Journal:  Antioxid Redox Signal       Date:  2015-05-14       Impact factor: 8.401

7.  Cooperation between PU.1 and CAAT/enhancer-binding protein beta is necessary to induce the expression of the MD-2 gene.

Authors:  Pierre Tissières; Tanguy Araud; Agnieszka Ochoda; Geneviève Drifte; Irène Dunn-Siegrist; Jérôme Pugin
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

Review 8.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

9.  An shRNA-based screen of splicing regulators identifies SFRS3 as a negative regulator of IL-1β secretion.

Authors:  Pedro Moura-Alves; Ana Neves-Costa; Helena Raquel; Teresa Raquel Pacheco; Bruno D'Almeida; Raquel Rodrigues; Iris Cadima-Couto; Ângelo Chora; Mariana Oliveira; Margarida Gama-Carvalho; Nir Hacohen; Luis F Moita
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

10.  Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism.

Authors:  Carlos del Fresno; Vanesa Gómez-Piña; Vanesa Lores; Alessandra Soares-Schanoski; Irene Fernández-Ruiz; Blas Rojo; Rodolfo Alvarez-Sala; Ernesto Caballero-Garrido; Felipe García; Tania Veliz; Francisco Arnalich; Pablo Fuentes-Prior; Francisco García-Río; Eduardo López-Collazo
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.